Health Affairs' Alan Weil interview Kelsey Owsley from the University of Arkansas for Medical Sciences on her new paper assessing whether the 340B drug pricing program leads to increase in oncology services in rural hospitals.

She and colleagues find that participation in 340B is correlated with increased likelihood of offering cancer care.

Order the June 2023 issue of Health Affairs.

Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.

Subscribe: RSS | Apple Podcasts | Spotify | Stitcher | Google Podcasts

Kelsey Owsley on 340B's Effect on Oncology Services